Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

janssen pharmaceutical k.k. - ustekinumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - ustekinumab (genetical recombination) - injection

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kyowa kirin malaysia sdn. bhd. - brodalumab -

European Union - English - EMA (European Medicines Agency)

leo pharma a/s - brodalumab - psoriasis - immunosuppressants - kyntheum is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - secukinumab 150mg;   - powder for injection - 150 mg - active: secukinumab 150mg   excipient: histidine hydrochloride monohydrate nitrogen polysorbate 80 sucrose - cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - secukinumab 150 mg/ml;   - solution for injection - 150 mg/ml - active: secukinumab 150 mg/ml   excipient: histidine hydrochloride monohydrate methionine nitrogen polysorbate 80 trehalose dihydrate water for injection - cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - secukinumab -

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - secukinumab - injection, powder, for solution - secukinumab 150 mg/vial